The influence of timing of Maternal administration of Antibiotics during cesarean section on the intestinal Microbial colonization in Infants (MAMI-trial): study protocol for a randomised controlled trial
- PMID: 31382981
- PMCID: PMC6683546
- DOI: 10.1186/s13063-019-3552-8
The influence of timing of Maternal administration of Antibiotics during cesarean section on the intestinal Microbial colonization in Infants (MAMI-trial): study protocol for a randomised controlled trial
Abstract
Background: A disturbance in the early colonisation of the gut by microorganisms is associated with an aberrant innate immune system and a variety of clinical conditions later in life. Several factors are considered to influence this initial colonisation, including maternally administered antibiotics during pregnancy and delivery. Recent revisions to international obstetric guidelines have resulted in the exposure of all infants born by caesarean section (CS) to broad-spectrum antibiotics perinatally. To date, the consequences of these new guidelines on neonatal gut colonisation and the associated short- and long-term health implications have not yet been addressed. The aim of this study is to investigate the influence of the timing of antibiotic administration during CS to the mother on the course of neonatal intestinal colonisation up to 2 years of age.
Methods/design: This single-centre randomised controlled trial will recruit 40 women scheduled for an elective CS. The subjects will be randomised to receive 1500 mg of cefuroxime intravenously either prior to the skin incision (n = 20) or after clamping of the umbilical cord (n = 20). Levels of cefuroxime in cord blood will be determined for exposed neonates. Faecal samples from the children will be collected on days 1, 7 and 28 days and at 2 years old and analysed by 16S sequencing. Shannon-diversity indices, absolute and relative abundances, and unsupervised and supervised classification methods will be used to evaluate the effect of the timing of intrapartum cefuroxime administration on the composition of the microbiota. The outcomes for both study groups will be compared to the intestinal microbiota of vaginally born infants (n = 20). To detect possible effects on health state, a questionnaire on health-related issues will be taken at the age of 2 years.
Discussion: In the proposed study, changes in the intestinal microbiota of 40 children born by CS will be followed until the age of 2 years. Research on this topic is necessary since significant effects relating to the timing of antibiotic administration on microbial colonisation may conflict with the current guidelines, as this may have health consequences later in life.
Trial registration: Netherlands Clinical Trial Registry, NTR6000 . Retrospectively registered on 25 July 2016.
Keywords: Antibiotics; Caesarean section; Infants; Intestinal microbiota.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
![Fig. 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6683546/bin/13063_2019_3552_Fig1_HTML.gif)
![Fig. 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6683546/bin/13063_2019_3552_Fig2_HTML.gif)
Similar articles
-
Influence of timing of maternal antibiotic administration during caesarean section on infant microbial colonisation: a randomised controlled trial.Gut. 2022 Sep;71(9):1803-1811. doi: 10.1136/gutjnl-2021-324767. Epub 2021 Nov 21. Gut. 2022. PMID: 34803023 Free PMC article. Clinical Trial.
-
Long-term impact of pre-incision antibiotics on children born by caesarean section: a longitudinal study based on UK electronic health records.Health Technol Assess. 2022 Jun;26(30):1-160. doi: 10.3310/ZYZC8514. Health Technol Assess. 2022. PMID: 35781133
-
The influence of prenatal and intrapartum antibiotics on intestinal microbiota colonisation in infants: A systematic review.J Infect. 2020 Aug;81(2):190-204. doi: 10.1016/j.jinf.2020.05.002. Epub 2020 May 7. J Infect. 2020. PMID: 32389786 Review.
-
Impact of Early Exposure to Cefuroxime on the Composition of the Gut Microbiota in Infants Following Cesarean Delivery.J Pediatr. 2019 Jul;210:99-105.e2. doi: 10.1016/j.jpeds.2019.03.001. Epub 2019 Apr 30. J Pediatr. 2019. PMID: 31053348 Clinical Trial.
-
Timing of intravenous prophylactic antibiotics for preventing postpartum infectious morbidity in women undergoing cesarean delivery.Cochrane Database Syst Rev. 2014 Dec 5;(12):CD009516. doi: 10.1002/14651858.CD009516.pub2. Cochrane Database Syst Rev. 2014. PMID: 25479008 Review.
Cited by
-
Microbiome-Gut-Mucosal-Immune-Brain Axis and Autism Spectrum Disorder (ASD): A Novel Proposal of the Role of the Gut Microbiome in ASD Aetiology.Behav Sci (Basel). 2023 Jun 30;13(7):548. doi: 10.3390/bs13070548. Behav Sci (Basel). 2023. PMID: 37503995 Free PMC article. Review.
-
Programming Factors of Neonatal Intestinal Dysbiosis as a Cause of Disease.Int J Mol Sci. 2023 Mar 17;24(6):5723. doi: 10.3390/ijms24065723. Int J Mol Sci. 2023. PMID: 36982799 Free PMC article. Review.
-
How much is the lack of retention evidence costing trial teams in Ireland and the UK?Trials. 2022 May 12;23(1):396. doi: 10.1186/s13063-022-06223-x. Trials. 2022. PMID: 35550607 Free PMC article.
-
Influence of timing of maternal antibiotic administration during caesarean section on infant microbial colonisation: a randomised controlled trial.Gut. 2022 Sep;71(9):1803-1811. doi: 10.1136/gutjnl-2021-324767. Epub 2021 Nov 21. Gut. 2022. PMID: 34803023 Free PMC article. Clinical Trial.
-
The Bifidogenic Effect Revisited-Ecology and Health Perspectives of Bifidobacterial Colonization in Early Life.Microorganisms. 2020 Nov 25;8(12):1855. doi: 10.3390/microorganisms8121855. Microorganisms. 2020. PMID: 33255636 Free PMC article. Review.
References
-
- Purchiaroni F, Tortora A, Gabrielli M, Bertucci F, Gigante G, Ianiro G, et al. The role of intestinal microbiota and the immune system. Eur Rev Med Pharmacol Sci. 2013;17(3):323–333. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical